European Journal of Chemistry 2014, 5(4), 612-617 | doi: https://doi.org/10.5155/eurjchem.5.4.612-617.1108 | Get rights and content

Issue cover





  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines


Suresh Mani (1) , Mashood Ahamed Fazul Mohamed (2) , Abdul Khader Karakkakal (3) , Syed Ali Padusha Mohamed Khan (4,*)

(1) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(2) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(3) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(4) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(*) Corresponding Author

Received: 11 Jun 2014 | Accepted: 18 Jul 2014 | Published: 31 Dec 2014 | Issue Date: December 2014

Abstract


A series of 2-hydroxypyrrolidine/piperidine derivatives (4a-h)/(4i-m) were prepared by reacting 2,3-dihydrofuran (2a)/3,4-dihydro-2H-pyran (2b) with various heterocyclic amines (3a-h), using FeCl3.6H2O as catalyst. The synthesized compounds were characterized by various physic chemical techniques such as elemental analysis and spectral analysis viz, 1H NMR, 13C NMR and Mass.


Announcements


One of our sponsors will cover the article processing fee for all submissions made between May 17, 2023 and June 16, 2023 (Voucher code: SPONSOR2023).

Editor-in-Chief
European Journal of Chemistry

Keywords


Catalysis; Androgenic alopecia; Anti-Cholinergic drug; FeCl3-catalysed C-N coupling; 2-Hydroxypiperidine analogs; 2-Hydroxypyrrolidine analogs

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.5.4.612-617.1108

Links for Article


| | | | | | |

| | | | | | |

| | | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 1805 times | icon graph PDF Article downloaded 584 times

Funding information


University Grants Commission, New Delhi, Major Research Project (Ref. No: 41-261/2012 (SR), Dated: 13-07-2012); Sophisticated Test and Instrumentation Centre (STIC), Cochin and Sophisticated Analytical Inst. Fac., Indian Institute of Technology, India

Citations

/


[1]. Sujit K. Ghorai, Vijaya G. Gopalsamuthiram, Anup M. Jawalekar, Rupesh E. Patre, Sitaram Pal
Iron catalyzed C N bond formation
Tetrahedron  73(14), 1769, 2017
DOI: 10.1016/j.tet.2017.02.033
/


[2]. Sergio L. Laurella, Mauricio F. Erben
Comment on “Structural and vibrational studies on 1-(5-Methyl- [1,3,4] thiadiazol-2-yl)-pyrolidin-2-ol” [Spectrochimica Acta Part A, 152 (2016) 252–261]. The importance of intramolecular OH⋯N hydrogen bonding in the conformational properties of thiadiazol-pyrrolidin-2-ol bearing species
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy  164, 40, 2016
DOI: 10.1016/j.saa.2016.03.018
/


[3]. N. Ramesh Babu, H. Saleem, S. Subashchandrabose, M. Syed Ali Padusha, S. Bharanidharan
Structural and vibrational studies on 1-(5-methyl-[1,3,4] thiadiazol-2-yl)-pyrolidin-2-ol
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy  152, 252, 2016
DOI: 10.1016/j.saa.2015.06.112
/


References


[1]. Lemos, V. A.; Santos, M. S.; Santos, E. S.; Santos, M. J. S.; Dos Santos, W. N. L.; Souza, A. S.; De Jesus, D. S.; DasVirgens, C. F.; Carvalho, M. S.; Oleszczuk, N.; Vale, M. G. R.; Welz, B.; Ferreira, S. L. C. Spectrochim. Acta B 2007, 62, 4-12.

[2]. Eleonora, D. I.; Nevena, I. P.; Rositca, D. N. Molecules 2012, 17, 4936-4949.
http://dx.doi.org/10.3390/molecules17054936

[3]. Sun, N.; Li, B.; Shao, J.; Mo, W.; Hu, B.; Shen, Z.; Hu, X. Beilstein J. Org. Chem. 2012, 8, 61-70.
http://dx.doi.org/10.3762/bjoc.8.6

[4]. Orvieto, F.; Branca, D.; Giomini, C.; Jones, P.; Koch, U.; Ontoria, J. M.; Palumbi, M. C.; Rowley, M.; Toniatti, C.; Muraglia, E. Bioorg. Med. Chem. Lett. 2009, 19, 4196-4200.
http://dx.doi.org/10.1016/j.bmcl.2009.05.113

[5]. David, G. I. K. J. Nat. Prod. 2009, 72, 507-515.
http://dx.doi.org/10.1021/np800568j

[6]. Sohl, W. E.; Shriner, R. L. J. Am. Chem. Soc. 1933, 55(9), 3828-3833.
http://dx.doi.org/10.1021/ja01336a066

[7]. Berding, G.; Gratz, K. F.; Kolbe, H.; Meyar, G. J.; Dengler, R.; Knoop, B. O.; Hundeshagen, H. Nuklearmedizin. 1994, 33, 194-199.

[8]. Ito, A.; Ohno, Y.; Nakamura, M. J. Pharmacol. Exp. Ther. 2010, 334, 171-181.
http://dx.doi.org/10.1124/jpet.110.167346

[9]. Gasparini, F.; Di Paolo, T.; Gomez-Mancilla, B. Parkinsons Dis. 2013, 2013, Article ID 196028, 11 pages.

[10]. Jakobsen, S. M.; Kersten, H.; Molden. E. J. Am. Geriatr. Soc. 2011, 59, 501-505.
http://dx.doi.org/10.1111/j.1532-5415.2010.03307.x

[11]. Imai, S.; Saito, S.; Takase, H.; Enomoto, M.; Aoyama, H.; Yamaji, S.; Yokoyama, K.; Yagi, H.; Kushiro, T.; Hirayama, T. Circ. J. 2008, 72, 709-715.
http://dx.doi.org/10.1253/circj.72.709

[12]. Nelson, M. Aust. Prescr. 2010, 33, 108-112.

[13]. Altman, D.; Granath, F.; Mattiasson, A.; Falconer, C. Int. Urogynecol. J. 2009, 20, 1285-1291.
http://dx.doi.org/10.1007/s00192-009-0957-z

[14]. Jha, S.; Parsons, M. ClinInterv Aging. 2006, 1, 309-316.
http://dx.doi.org/10.2147/ciia.2006.1.4.309

[15]. Staskin, D. R.; MacDiarmid, S. A. Am. J. Med. 2006, 119, 9-15.
http://dx.doi.org/10.1016/j.amjmed.2005.12.011

[16]. Areej, M. A. H.; Fatma, U. A.; Mutasem, O. T. J. Mol. Graphics Model. 2007, 26, 443-456.
http://dx.doi.org/10.1016/j.jmgm.2007.02.002

[17]. Liu, Y.; Zhang, J.; Xu, W. Curr. Med. Chem. 2007, 14, 2872-2891.
http://dx.doi.org/10.2174/092986707782360024

[18]. Zhang, A.; Xu, W. Mini-Rev. Med. Chem. 2006, 6, 429-448.
http://dx.doi.org/10.2174/138955706776361475

[19]. Anderson, J. M. Am. Fam. Physician. 2007, 75(6), 875-882.

[20]. Bais, J. M.; Eskes, M.; Pel, M.; Bonsel, G. J.; Bleker, O. P. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 115, 166-172.

[21]. Magann, E. F.; Evans, S.; Chauhan, S. P.; Lanneau, G.; Fisk, A. D.; Morrison, J. C. Obstet. Gynecol. 2005, 105, 290-293.
http://dx.doi.org/10.1097/01.AOG.0000151993.83276.70

[22]. Anderson, J. M.; Etches, D. Am. Fam. Physician. 2007, 75, 875-882.

[23]. Reyes, O. A.; Gonzalez, G. M. J ObstetGynaecol Can. 2011, 33(11), 1099-1104.

[24]. Gimpl, G.; Postina, R.; Fahrenholz, F.; Reinheimer, T. Eur. J. Pharmacol. 2005, 510(1-2), 9-16.
http://dx.doi.org/10.1016/j.ejphar.2005.01.010

[25]. Osvaldo, A.; Reyes, M. D.; Geneva, M.; Gonzalez, M. D. J. Obstet. Gynaecol. Can. 2011, 33(11), 1099-1104.

[26]. Chouthaiwale, P. V.; Kotkar, S. P.; Sudalai, A. Arkivoc 2009, 2, 88-94.
http://dx.doi.org/10.3998/ark.5550190.0010.210

[27]. Dhawan, P.; Bell, A.; Kumar, A.; Golden, C.; Metha, K. D. J. Lipid Res. 1999, 40, 1911-1919.

[28]. Ahren, B.; Landin-Olsson, M.; Jansson, PA.; Svensson, M.; Holmes, D.; Schweizer, A. J. Clin. Endocrinol. Metab. 2004, 89(5), 2078-2084.
http://dx.doi.org/10.1210/jc.2003-031907

[29]. Attilakos, G.; Psaroudakis, D.; Ash, J.; Buchanan, R.; Winter, C.; Donald, F.; Hunt, L. P.; Draycotta, T. Int. J.Gynaecol. Obstet. 2010, 117(8), 929-936.
http://dx.doi.org/10.1111/j.1471-0528.2010.02585.x

[30]. Dunning, B. E.; Gerich J. E. Endocrine Rev.2007, 28, 3253-3283.
http://dx.doi.org/10.1210/er.2006-0026

[31]. Reddy, K. R.; Krishna, G. G.; Rajasekhar, C. V. Synth. Commun. 2007, 37, 4289-4299.
http://dx.doi.org/10.1080/00397910701575335

[32]. Bhanja, C.; Jena, S.; Nayak, S.; Mohapatra, S. Beilstein. J. Org. Chem. 2012, 8, 1668-1694.
http://dx.doi.org/10.3762/bjoc.8.191

[33]. Matthew, J.; Gaunt, C. C.; Johansson, A. M.; Ngoc T. V. Drug Discov. Today 2007, 12, 8-27.
http://dx.doi.org/10.1016/j.drudis.2006.11.004

[34]. Paterson, S. Br. J. Clin. Pharmacol. 1992, 33, 449-450.
http://dx.doi.org/10.1111/j.1365-2125.1992.tb04066.x

[35]. Arnsten, A. F.; Li, B. M. Biol. Psychiat. 2004, 57(11), 1377-1384.
http://dx.doi.org/10.1016/j.biopsych.2004.08.019

[36]. Kimko, H. C.; Cross, J. T.; Abernethy, D. R. Clin. Pharmacokinet. 1999, 37, 457-470.
http://dx.doi.org/10.2165/00003088-199937060-00002

[37]. Markowitz, J. S.; Devane, C. L.; Boulton, D. W.; Nahas, Z.; Risch, S. C.; Diamond, F.; Patrick, K. S. Drug Metab. Dispo. 2000, 28, 620-624.

[38]. David, H.; Kim, D. H.; Vaccaro, A. R. Spine J. 2006, 6, 479-487.
http://dx.doi.org/10.1016/j.spinee.2006.06.050

[39]. Singh, M.; Magon, N.; Singh, T. J. Midlife Health. 2013, 3, 76-80.

[40]. Report of a WHO Study Group. World Health Organ Tech. Rep. Ser. 1994, 843, 1-129.

[41]. Scow, D. T.; Nolte, R. S.; Shaughnessy, A. F. Am. Fam. Physician. 1999, 59, 2189-2194.

[42]. Balakrishnan, P.; Shanmugam, S.; Lee, W. S.; Lee, W. M.; Kim, J. O.; Oh, D. H.; Kim, D.; Kim, J. S.; Yoo, B. K.; Choi, H.; Woo, J. S.; Yong, C. S. Int. J. Pharm. 2009, 377, 1-8.
http://dx.doi.org/10.1016/j.ijpharm.2009.04.020

[43]. Varma, P. P.; Mahadevan, K. M.; Khader, A.; Hulikal, V. Org. Comm. 2011, 4(3), 52-57.


How to cite


Mani, S.; Mohamed, M.; Karakkakal, A.; Khan, S. Eur. J. Chem. 2014, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108
Mani, S.; Mohamed, M.; Karakkakal, A.; Khan, S. FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines. Eur. J. Chem. 2014, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108
Mani, S., Mohamed, M., Karakkakal, A., & Khan, S. (2014). FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines. European Journal of Chemistry, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108
Mani, Suresh, Mashood Ahamed Fazul Mohamed, Abdul Khader Karakkakal, & Syed Ali Padusha Mohamed Khan. "FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines." European Journal of Chemistry [Online], 5.4 (2014): 612-617. Web. 4 Jun. 2023
Mani, Suresh, Mohamed, Mashood, Karakkakal, Abdul, AND Khan, Syed. "FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines" European Journal of Chemistry [Online], Volume 5 Number 4 (31 December 2014)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.5.4.612-617.1108


CrossRef | Scilit | GrowKudos | Researchgate | Publons | ScienceGate | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2014, 5(4), 612-617 | doi: https://doi.org/10.5155/eurjchem.5.4.612-617.1108 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c)





© Copyright 2010 - 2023  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.